Gonadorelin (GnRH)


Decapeptide GnRH agonist

Synthetic gonadotropin-releasing hormone, used clinically for diagnostic GnRH stimulation testing and for stimulation of LH/FSH release.

Abstract

Gonadorelin (GnRH, LHRH; CAS 9034-40-6; molecular formula C55H75N17O13; molecular weight 1182.31) is the synthetic decapeptide form of gonadotropin-releasing hormone. The compound is FDA-approved (Factrel) for diagnostic GnRH stimulation testing of pituitary gonadotropin reserve. Pulsatile administration (every 90 minutes) produces physiological LH/FSH release; continuous administration produces receptor downregulation and gonadotropin suppression (the basis for the leuprolide/goserelin class of long-acting analogs used in prostate cancer and endometriosis). Pharmacokinetics: plasma half-life 2 to 4 minutes. Research-grade applications use the compound for stimulation of endogenous gonadotropin release on testosterone restoration protocols.

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.


Browse all monographs

Previous monograph
Next monograph